# Study of Iguratimod in Sjögren's Syndrome

> **NCT03023592** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Peking Union Medical College Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Sjogren's Syndrome

## Interventions

- **DRUG:** Iguratimod

## Key facts

- **NCT ID:** NCT03023592
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-02
- **Primary completion:** 2018-02
- **Final completion:** 2018-04
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2017-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03023592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03023592, "Study of Iguratimod in Sjögren's Syndrome". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03023592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*